Chimeric IL-1 receptor type I antagonists
    2.
    发明授权
    Chimeric IL-1 receptor type I antagonists 有权
    嵌合IL-1受体I型拮抗剂

    公开(公告)号:US08853150B2

    公开(公告)日:2014-10-07

    申请号:US13812582

    申请日:2011-07-29

    摘要: Featured herein are non-naturally occurring cytokine domains that can be used, inter alia, to modulate cellular signalling responsive to interleukin-1 receptor I (IL-1 RI), to treat disorders, and to detect and/or bind to cellular receptors, as well as other agents. Exemplary cytokine domains can contain amino acid residues from at least two parental cytokines domains, for example, receptor binding features, surface features, β strands, and loops from at least two parental cytokines domains.

    摘要翻译: 本文特征在于非天然存在的细胞因子结构域,其可以用于调节对白细胞介素-1受体I(IL-1RI)的响应的细胞信号传导,以治疗病症,以及检测和/或结合细胞受体, 以及其他代理商。 示例性细胞因子结构域可以含有至少两个亲本细胞因子结构域的氨基酸残基,例如受体结合特征,表面特征, 链和环,其来自至少两个亲本细胞因子结构域。

    CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS
    3.
    发明申请
    CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS 有权
    CHIMERIC IL-1受体I型激动剂和拮抗剂

    公开(公告)号:US20130209396A1

    公开(公告)日:2013-08-15

    申请号:US13812582

    申请日:2011-07-29

    IPC分类号: C07K14/545

    摘要: Featured herein are non-naturally occurring cytokine domains that can be used, inter alia, to modulate cellular signalling responsive to interleukin-1 receptor I (IL-1 RI), to treat disorders, and to detect and/or bind to cellular receptors, as well as other agents. Exemplary cytokine domains can contain amino acid residues from at least two parental cytokines domains, for example, receptor binding features, surface features, β strands, and loops from at least two parental cytokines domains.

    摘要翻译: 本文特征在于非天然存在的细胞因子结构域,其可以用于调节对白细胞介素-1受体I(IL-1RI)的响应的细胞信号传导,以治疗病症,以及检测和/或结合细胞受体, 以及其他代理商。 示例性细胞因子结构域可以包含来自至少两个亲本细胞因子结构域的氨基酸残基,例如受体结合特征,表面特征,β链和来自至少两个亲本细胞因子结构域的环。